pinocembrin has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Liu, Z; Wan, W; Yang, B; Ye, T; Yu, Y; Zhang, C | 1 |
| Bo, Y; Cui, Z; Tianxin, Y; Weiguo, W; Yi, Y; Zhangchi, L | 1 |
| Li, X; Ma, W; Ma, X; Miao, Y; Ning, W; Xi, B; Yang, C; Zhai, Y; Zhang, J; Zhao, Y; Zhou, H | 1 |
3 other study(ies) available for pinocembrin and Cirrhosis
| Article | Year |
|---|---|
Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Caspase 1; Collagen Type I; Connexins; Disease Models, Animal; Fibrosis; Heart Atria; Inflammation; Ion Channels; Isoproterenol; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley | 2022 |
Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
Topics: Animals; Atrial Fibrillation; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Fibrosis; Monocrotaline; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2023 |
Pinocembrin Ameliorates Skin Fibrosis via Inhibiting TGF-β1 Signaling Pathway.
Topics: Animals; Animals, Newborn; Cell Movement; Cell Proliferation; Female; Fibroblasts; Fibrosis; Flavanones; Flavonoids; Humans; In Vitro Techniques; Keloid; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Skin; Transforming Growth Factor beta1; Wound Healing | 2021 |